Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionnuclear thyroid hormone receptor binding

TRIP12 MED12 MED1

6.79e-0634223GO:0046966
GeneOntologyMolecularFunctionnuclear vitamin D receptor binding

MED12 MED1

1.75e-0418222GO:0042809
GeneOntologyMolecularFunctionmicrotubule plus-end binding

APC DST

2.64e-0422222GO:0051010
GeneOntologyMolecularFunctionnuclear receptor binding

TRIP12 MED12 MED1

1.09e-03187223GO:0016922
GeneOntologyMolecularFunctionnuclear receptor coactivator activity

MED12 MED1

2.04e-0361222GO:0030374
GeneOntologyMolecularFunctiontranscription coactivator activity

MED12 WWC1 MED1

4.30e-03303223GO:0003713
GeneOntologyMolecularFunctionmicrotubule binding

APC CAMSAP2 DST

4.50e-03308223GO:0008017
GeneOntologyCellularComponentGolgi lumen

MUC16 MUC3A MUC5B

2.58e-04109243GO:0005796
GeneOntologyCellularComponentmediator complex

MED12 MED1

8.21e-0437242GO:0016592
GeneOntologyCellularComponentmicrotubule end

CAMSAP2 DST

8.66e-0438242GO:1990752
Domain-

CAMSAP2 SPECC1 DST

8.83e-05712331.10.418.10
DomainCH

CAMSAP2 SPECC1 DST

9.59e-0573233PS50021
DomainCH-domain

CAMSAP2 SPECC1 DST

1.04e-0475233IPR001715
DomainSEA

MUC16 MUC3A

1.31e-0414232SM00200
DomainSEA

MUC16 MUC3A

3.61e-0423232PS50024
DomainSEA_dom

MUC16 MUC3A

3.61e-0423232IPR000082
Domain-

APC TRIP12 MED12

2.46e-032222331.25.10.10
DomainCH

SPECC1 DST

2.88e-0365232SM00033
DomainCH

SPECC1 DST

3.33e-0370232PF00307
DomainPrefoldin

HSF2 SPECC1

3.52e-0372232IPR009053
DomainARM-like

APC TRIP12 MED12

4.27e-03270233IPR011989
DomainC2

WWC1 SYTL2

1.12e-02131232PF00168
DomainC2

WWC1 SYTL2

1.31e-02142232PS50004
Domain-

WWC1 SYTL2

1.41e-021482322.60.40.150
PathwayREACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC

MUC16 MUC3A MUC5B

5.41e-0716153M27410
PathwayREACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS

MUC16 MUC3A MUC5B

6.57e-0717153M27412
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC16 MUC3A MUC5B

1.70e-0623153M556
PathwayREACTOME_DECTIN_2_FAMILY

MUC16 MUC3A MUC5B

2.50e-0626153M27483
PathwayREACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS

MUC16 MUC3A MUC5B

3.55e-0562153M546
PathwayREACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS

MUC16 MUC3A MUC5B

4.69e-0568153M27303
PathwayBIOCARTA_PITX2_PATHWAY

APC MED1

1.10e-0415152MM1439
PathwayBIOCARTA_PITX2_PATHWAY

APC MED1

1.26e-0416152M8516
PathwayREACTOME_O_LINKED_GLYCOSYLATION

MUC16 MUC3A MUC5B

2.02e-04111153M27416
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC16 MUC5B

2.19e-0421152MM15706
PathwayREACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS

MUC16 MUC3A MUC5B

4.00e-04140153M27484
PathwayREACTOME_DISEASES_OF_GLYCOSYLATION

MUC16 MUC3A MUC5B

4.25e-04143153M27275
PathwayREACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS

MUC16 MUC5B

1.81e-0360152MM15636
PathwayPID_ERA_GENOMIC_PATHWAY

HSF2 MED1

2.05e-0364152M200
PathwayREACTOME_DISEASES_OF_METABOLISM

MUC16 MUC3A MUC5B

2.14e-03250153M27554
PathwayPID_BETA_CATENIN_NUC_PATHWAY

APC MED12

3.18e-0380152M223
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION

MED12 MED1

3.50e-0384152M1008
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

APC CAMSAP2 CAPRIN1 TANC1 WWC1 DST

5.39e-0920924636779422
Pubmed

Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.

MUC16 MUC3A MUC5B

2.34e-071824318834073
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

APC CAMSAP2 SPECC1 TRIP12 CAPRIN1 MED12 WWC1 MED1

1.18e-06124724827684187
Pubmed

DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.

MUC16 MUC5B

1.37e-06324227230679
Pubmed

Mediator facilitates transcriptional activation and dynamic long-range contacts at the IgH locus during class switch recombination.

MED12 MED1

1.37e-06324226903242
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

APC CAMSAP2 SPECC1 MED12 SLC5A6 TANC1 DST MED1

4.59e-06149724831527615
Pubmed

An EB1-binding motif acts as a microtubule tip localization signal.

APC DST

6.83e-06624219632184
Pubmed

Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.

MUC16 MUC5B

6.83e-06624219110483
Pubmed

Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.

APC TRIP12 CAPRIN1 MED12

9.33e-0619524417110338
Pubmed

Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation.

MED12 MED1

9.56e-06724218691967
Pubmed

Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.

LZTS3 APC CAMSAP2 SPECC1 MAP3K13

9.88e-0643024532581705
Pubmed

A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.

CAPRIN1 MED12 TANC1 DST MED1

1.55e-0547224538943005
Pubmed

Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha.

MED12 MED1

1.64e-05924214636573
Pubmed

Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex.

MED12 MED1

1.64e-0592428710870
Pubmed

A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression.

MED12 MED1

2.05e-051024212218053
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

APC CAMSAP2 SPECC1 TRIP12 TANC1 DST

2.08e-0586124636931259
Pubmed

Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis.

MED12 MED1

2.50e-051124212037571
Pubmed

A conserved Mediator-CDK8 kinase module association regulates Mediator-RNA polymerase II interaction.

MED12 MED1

3.00e-051224223563140
Pubmed

A novel docking site on Mediator is critical for activation by VP16 in mammalian cells.

MED12 MED1

3.54e-051324214657022
Pubmed

CDK8 is a positive regulator of transcriptional elongation within the serum response network.

MED12 MED1

3.54e-051324220098423
Pubmed

MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis.

MED12 MED1

3.54e-051324227570068
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

LZTS3 APC CAMSAP2 SPECC1 CAPRIN1 TANC1 DST

3.67e-05143124737142655
Pubmed

Cooperative activity of cdk8 and GCN5L within Mediator directs tandem phosphoacetylation of histone H3.

MED12 MED1

4.77e-051524218418385
Pubmed

The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair.

CAMSAP2 TRIP12 TANC1

5.32e-0510624331024071
Pubmed

The USA-derived transcriptional coactivator PC2 is a submodule of TRAP/SMCC and acts synergistically with other PCs.

MED12 MED1

5.44e-051624210882111
Pubmed

Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex.

MED12 MED1

6.17e-051724210235266
Pubmed

Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators.

MED12 MED1

6.94e-051824210198638
Pubmed

Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.

TRIP12 MED1

6.94e-05182427776974
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

COIL TRIP12 CAPRIN1 MED12 DST

7.26e-0565324522586326
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

COIL APC TRIP12 MED12 DST MED1

7.44e-05108224638697112
Pubmed

An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis.

MED12 MED1

7.75e-051924216799563
Pubmed

Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.

APC DST

8.61e-052024221689717
Pubmed

STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation.

MED12 MED1

8.61e-052024217967894
Pubmed

Structural and functional organization of TRAP220, the TRAP/mediator subunit that is targeted by nuclear receptors.

MED12 MED1

8.61e-052024215340084
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

APC SPECC1 DST SYTL2

8.84e-0534724417114649
Pubmed

The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro.

MED12 MED1

1.05e-042224211867769
Pubmed

Identification of mammalian Mediator subunits with similarities to yeast Mediator subunits Srb5, Srb6, Med11, and Rox3.

MED12 MED1

1.05e-042224212584197
Pubmed

Composite co-activator ARC mediates chromatin-directed transcriptional activation.

MED12 MED1

1.14e-042324210235267
Pubmed

Mediator complex proximal Tail subunit MED30 is critical for Mediator core stability and cardiomyocyte transcriptional network.

MED12 MED1

1.47e-042624234506481
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

COIL HSF2 TRIP12 MED12 MED1

1.47e-0475924535915203
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

COIL APC TRIP12 MUC16 DST

1.64e-0477724535844135
Pubmed

The cell proliferation antigen Ki-67 organises heterochromatin.

COIL CAPRIN1 MED12 DST

1.68e-0441024426949251
Pubmed

Mediator and cohesin connect gene expression and chromatin architecture.

MED12 MED1

1.71e-042824220720539
Pubmed

A mammalian mediator subunit that shares properties with Saccharomyces cerevisiae mediator subunit Cse2.

MED12 MED1

1.83e-042924214638676
Pubmed

The SCF-Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with Mediator.

MED12 MED1

2.10e-043124223322298
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

APC TRIP12 CAPRIN1 MED1

2.20e-0444024434244565
Pubmed

TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains.

TRIP12 MED1

2.38e-043324233567268
Pubmed

MED1/TRAP220 exists predominantly in a TRAP/ Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription.

MED12 MED1

2.53e-043424215989967
Pubmed

Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.

LZTS3 CAMSAP2 TANC1

3.32e-0419724336604605
Pubmed

Temporal regulation of the Mediator complex during muscle proliferation, differentiation, regeneration, aging, and disease.

MED12 MED1

3.33e-043924238690566
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

TRIP12 CAPRIN1 MED1

3.57e-0420224333005030
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

COIL APC TRIP12 MED1

3.65e-0450324416964243
Pubmed

Proteome-wide analysis of phospho-regulated PDZ domain interactions.

APC TANC1

3.86e-044224230126976
Pubmed

Protein interaction studies in human induced neurons indicate convergent biology underlying autism spectrum disorders.

APC TRIP12

4.05e-044324236950384
Pubmed

Impact of WIN site inhibitor on the WDR5 interactome.

HSF2 SPECC1

4.05e-044324233472061
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

LZTS3 APC CAMSAP2 CAPRIN1 DST

4.42e-0496324528671696
Pubmed

A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology.

MED12 MED1

4.84e-044724215175163
Pubmed

Protein interactome reveals converging molecular pathways among autism disorders.

COIL LZTS3 SPECC1 CAPRIN1

5.47e-0456024421653829
Pubmed

Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.

APC CAPRIN1 MED12

6.04e-0424224334011540
InteractionYWHAH interactions

APC CAMSAP2 SPECC1 TRIP12 TESPA1 TANC1 WWC1 DST MED1

1.72e-061102239int:YWHAH
InteractionYWHAE interactions

APC CAMSAP2 SPECC1 TRIP12 CAPRIN1 TESPA1 TANC1 WWC1 DST

5.07e-061256239int:YWHAE
InteractionMAPRE3 interactions

APC CAMSAP2 SPECC1 TANC1 DST

5.27e-06230235int:MAPRE3
InteractionYWHAB interactions

APC CAMSAP2 SPECC1 TRIP12 TESPA1 TANC1 WWC1 DST

9.95e-061014238int:YWHAB
InteractionDCTN1 interactions

APC CAMSAP2 SPECC1 CAPRIN1 WWC1 DST

1.54e-05497236int:DCTN1
InteractionMAPRE1 interactions

APC CAMSAP2 SPECC1 CAPRIN1 TANC1 DST

1.87e-05514236int:MAPRE1
InteractionYWHAQ interactions

APC CAMSAP2 SPECC1 TRIP12 TANC1 WWC1 DST MED1

2.03e-051118238int:YWHAQ
InteractionGSK3B interactions

APC CAMSAP2 TRIP12 CAPRIN1 TANC1 WWC1 DST

3.59e-05868237int:GSK3B
InteractionYWHAG interactions

APC CAMSAP2 SPECC1 TRIP12 TESPA1 TANC1 WWC1 DST

4.48e-051248238int:YWHAG
InteractionNUP43 interactions

COIL HSF2 APC TRIP12 MED12 DST

5.58e-05625236int:NUP43
InteractionTNIK interactions

LZTS3 APC CAPRIN1 WWC1 DST

5.98e-05381235int:TNIK
InteractionSFN interactions

APC CAMSAP2 SPECC1 TRIP12 TANC1 DST

9.82e-05692236int:SFN
InteractionSLC6A4 interactions

LZTS3 APC CAMSAP2 SPECC1 MAP3K13

1.14e-04437235int:SLC6A4
InteractionGSK3A interactions

APC CAMSAP2 TANC1 WWC1 DST

1.51e-04464235int:GSK3A
InteractionCEP128 interactions

LZTS3 APC CAMSAP2 TANC1

3.28e-04297234int:CEP128
GeneFamilyCD molecules|Mucins

MUC22 MUC16 MUC3A MUC5B

3.17e-0921174648
GeneFamilyCyclins|Mediator complex

MED12 MED1

4.32e-04331721061
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

APC WWC1 SYTL2

6.05e-04181173694
CoexpressionGSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN

COIL CAMSAP2 CAPRIN1 DST

5.68e-06130244M6087
CoexpressionNABA_ECM_AFFILIATED

MUC22 MUC16 MUC3A MUC5B

1.64e-05170244M5880
ToppCellTracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 MUC5B TANC1 WWC1 MAP3K13

6.55e-08200245d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCellTracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 MUC5B TANC1 WWC1 MAP3K13

6.55e-082002450eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 MUC5B TANC1 SYTL2

2.42e-061792446e965e424eebef50f0202cff75f458be395cfca1
ToppCellChildren_(3_yrs)-Immune-mast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

SPECC1 TESPA1 SYTL2

6.44e-05146243f7349d63bb47f1f22ced8ff514edc1c11bc782e7
ToppCellAdult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor

SPECC1 TESPA1 SYTL2

7.70e-051552437c9de0591d1bf756b8e268b278bbe10bd5415dcd
ToppCellChildren_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

SPECC1 TESPA1 SYTL2

7.99e-05157243ec185dbeabb67fd9ca85f71cab88463b60f9b1c1
ToppCellControl-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class

SPECC1 TANC1 SYTL2

8.30e-051592436f50c381cd8a26a5a90bf0ce909713cea96910d7
ToppCellPND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MUC3A MUC5B WWC1

8.46e-05160243028b5261a1da832d52f66fb620db83e5fbbd874a
ToppCellPND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MUC3A MUC5B WWC1

8.46e-051602431f4ee446436726c3d373f56d87dd80b6a12e8b9e
ToppCellAdult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor

SPECC1 TESPA1 SYTL2

8.61e-0516124344f5c0256b3ce264a6c7b62740f32dcd45ee052d
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LZTS3 MUC16 SYTL2

9.94e-0516924340b557549fe08c5dc9dba359af35993d68d1640a
ToppCellCOVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type

SPECC1 TESPA1 SYTL2

1.01e-04170243e90f18e5462381b38e918442b38b1c8105291908
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPECC1 CD300C DST

1.01e-041702437bba77ae34a0259fad6ee98cf665ff50f77a1328
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPECC1 CD300C DST

1.01e-04170243a43b977a7fe745536cf96b7c080397d9fa73086b
ToppCellCOVID-19_Severe-NK_CD56bright|COVID-19_Severe / Disease condition and Cell class

SPECC1 CD300C DST

1.03e-041712435810f790012a0750ca3378595514f66a99f123be
ToppCellImmune-mast_cell|World / Lineage, Cell type, age group and donor

SPECC1 TESPA1 SYTL2

1.05e-041722436e8e0aac5a20dbc789bf8c6916833bb8709a411a
ToppCelldroplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TESPA1 MUC5B SLC5A6

1.12e-0417624391ad2c34144f72283ca112fd3b3784f2f6259f65
ToppCell(03)_Secretory|World / shred by cell type and Timepoint

LZTS3 MUC16 MUC5B

1.12e-04176243cb7b1945788196ca79007f0768b6576ec885a0e5
ToppCellCOVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type

SPECC1 TESPA1 SYTL2

1.12e-04176243473c45a381ca109207d66ed1635668b391ea0e1f
ToppCellControl-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class

TESPA1 TANC1 SYTL2

1.12e-041762430c5916d63e1ada09105e46d2429b75129b7329ec
ToppCellASK440-Immune-Mast_cell|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

SPECC1 TESPA1 SYTL2

1.16e-04178243dcefc4afca3a40d1bd44722e66bca6b45a6c6c55
ToppCellnucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC16 MUC3A MUC5B

1.18e-04179243859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCellCOVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class

SPECC1 CD300C DST

1.18e-0417924390e7a4af195aa2332b07a9f06cde63e72ff49255
ToppCellnucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC16 MUC3A MUC5B

1.20e-041802433dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCellnucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC16 MUC3A MUC5B

1.20e-04180243668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCelldroplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TANC1 DST SYTL2

1.26e-0418324303c7e69136d5a3b9c5b2c91733e9b1c791f45c49
ToppCellControl-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations)

MUC16 MUC3A MUC5B

1.26e-0418324315d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCellIPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class

SPECC1 TESPA1 SYTL2

1.28e-041842437326a16d7d3ae41b8c9d2beaec7f977b374f3469
ToppCellCOVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

SPECC1 MUC3A SYTL2

1.28e-0418424321790cdfa3b4036ad413fd44b94e31563116f25f
ToppCellControl-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations)

MUC16 MUC3A MUC5B

1.28e-04184243d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

TESPA1 DST SYTL2

1.28e-04184243d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor

TANC1 WWC1 DST

1.30e-0418524332b4e68e551d435a732f253f6ad83408c759a642
ToppCell(5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

MUC16 MUC5B SYTL2

1.32e-04186243219b1aeca17503244fabbb780bca58f22c7c0f27
ToppCelldroplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TANC1 DST SYTL2

1.32e-041862438eafd4bea692f7ef33de27dd53f9d1fe67deaad8
ToppCell10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue

SPECC1 TESPA1 TANC1

1.34e-04187243f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0
ToppCell10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue

SPECC1 TESPA1 TANC1

1.34e-04187243da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPECC1 CD300C DST

1.36e-041882438431991e68b8e9c5eb72212460f6da679ea3b85a
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 MUC5B SYTL2

1.36e-041882435901b276f2379abf486b8285957277e95f08464e
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPECC1 CD300C DST

1.36e-04188243d8f10b3ad11bc99a63f44560e39791085256e5c8
ToppCellCOPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class

TANC1 WWC1 SYTL2

1.36e-04188243186fe1ea328c942910190a4240262c0d8642ea3b
ToppCellASK440-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq

SPECC1 TESPA1 SYTL2

1.38e-0418924372a19b20cb0f7283afe5f85d62a21cff69fd78d0
ToppCell10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue

TANC1 DST SYTL2

1.41e-041902430c7eb8f4f2926af01bf44d5c9f239be7b81c67fe
ToppCelldroplet-Kidney-nan-21m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TANC1 DST SYTL2

1.41e-04190243c247562df3e1aa3173c9f01a74d5831f0764a1b2
ToppCelldroplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TANC1 DST SYTL2

1.41e-041902435cea8298c8336c136ba009630c9e48d4bc832cb2
ToppCellCOPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class

TESPA1 TANC1 SYTL2

1.41e-04190243379dbac19110b76079a7a53209569e060a852acb
ToppCelldroplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TANC1 DST SYTL2

1.43e-041912435a5b5402a077b3189ca156f2bac5f47ad780aebf
ToppCelldroplet-Kidney-KIDNEY-30m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TANC1 DST SYTL2

1.43e-0419124378bcce497920cc5b3bef083eab50deb1cc82cd2e
ToppCelldroplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TANC1 DST SYTL2

1.43e-04191243297bc79adc5fef211497819b4861b52cd26ac754
ToppCelldroplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TANC1 DST SYTL2

1.43e-04191243e1ec165ba6578cefd88895e7e183190e79f733a4
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SPECC1 DST SYTL2

1.45e-04192243df4741e7684f010445f0224a1fd61aaa4fae02b3
ToppCellAdult-Epithelial|Adult / Lineage, Cell type, age group and donor

TANC1 WWC1 MAP3K13

1.45e-04192243efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCelldroplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TANC1 DST SYTL2

1.45e-0419224361c2caf6c838132ed5faa8791c288f2149eba2c8
ToppCelldroplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TANC1 DST SYTL2

1.45e-04192243e19e3e8edcc08e4a67873bfb6e46489ca6c8756a
ToppCellcellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC16 MUC5B SYTL2

1.47e-0419324371bf8fb5314b79cb30f4eb9c8459b21f10cd6d35
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPECC1 MAP3K13 CD300C

1.47e-0419324389c63dd5d97fbd92ea308405b7e8e630dda5158d
ToppCellcellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC16 MUC5B SYTL2

1.47e-04193243b05e110b13d35d34294357c8e1c4fd23bf4b6c92
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPECC1 MAP3K13 CD300C

1.47e-041932437842f29c16fe3a289ed3861fa570430142d2363f
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SPECC1 TANC1 DST

1.49e-0419424390efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SPECC1 TANC1 DST

1.49e-04194243df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCellBronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 MUC5B WWC1

1.52e-04195243e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell(010)_cDC|World / immune cells in Peripheral Blood (logTPM normalization)

SPECC1 CD300C DST

1.52e-041952434aabb3f5ce70100e4d98d7fa9f8d12e84fb9fe3d
ToppCellCOVID-19_Moderate-cDC|World / disease group, cell group and cell class

SPECC1 CD300C DST

1.54e-0419624392a236adf386f05d020b1954bbdc5bd32346cbf0
ToppCellfacs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIP12 CAPRIN1 TANC1

1.54e-0419624344f5b1b474399c9316729155f2ea95a82ca66e30
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 MUC5B SYTL2

1.54e-041962437a4d502550e9e37dc42f2ff1be3c896afe365d7f
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 MUC5B SYTL2

1.54e-04196243a52879a4c822c5e4be569f01f845a795e00c5f4b
ToppCellBronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X

MUC16 MUC5B SYTL2

1.54e-04196243057d150bdf0cad959fd03ec2d1560a96ba03fae9
ToppCellfacs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIP12 CAPRIN1 TANC1

1.54e-04196243c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8
ToppCellPBMC-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

SPECC1 CD300C DST

1.56e-041972439162ede5572326c00ede0769fe7f4e0dd14d2340
ToppCellPBMC-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPECC1 CD300C DST

1.56e-041972430460b6907743a354792b5bc40bff01aac7c41684
ToppCellCOVID-19_Mild-Myeloid-cDC|COVID-19_Mild / Disease group, lineage and cell class

SPECC1 CD300C DST

1.56e-041972432901904b8a791fac2668fd737eff7e7144378db4
ToppCellBronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SPECC1 TESPA1 SYTL2

1.56e-04197243bed8a9b73af5caee51b1232b31c24a59353658df
ToppCellBronchial-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SPECC1 TESPA1 SYTL2

1.56e-04197243b7d5073d44aa1e2cb83ea8d8104c5ed662665755
ToppCellBronchial_Biopsy-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

MUC16 MUC5B SYTL2

1.56e-041972433f5dfa892a1f631b96eeb6f4cfc284aee51d1ce6
ToppCellPBMC-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPECC1 CD300C DST

1.56e-04197243021c9c48375259b808e1f36a029c4fe6971c00eb
ToppCellPBMC-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

SPECC1 CD300C DST

1.56e-0419724318df0e447bcea2a405a357563f87bacc57466227
ToppCellCOVID-19_Moderate-cDC|COVID-19_Moderate / disease group, cell group and cell class

SPECC1 CD300C DST

1.56e-04197243ff45a212434a1b128e1a217c6abdec6380938da9
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 MUC5B SYTL2

1.59e-04198243af07a970afaa435c6433bb5c1cbff4c67af350c7
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 MUC5B SYTL2

1.61e-041992437223f853335492ca617dbec3e4b6872a8a463a45
ToppCellTracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 MUC5B WWC1

1.61e-04199243ef1a0c278c23614fd6a3218a9733abe6ecd6f686
ToppCell(04)_Interm._basal>secr.|World / shred by cell type by condition

MUC16 MUC5B SYTL2

1.61e-04199243ed399244433f781fc291a9bff16825b8a3ca294f
ToppCellTracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Mucous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 MUC5B WWC1

1.61e-04199243f37114cf849837fdb8ed9a767de773e8681b7df3
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 MUC5B SYTL2

1.61e-04199243e03bdc7cb825e287f41b834ec6061d23c1c03b04
ToppCellBronchial-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TESPA1 TANC1 SYTL2

1.61e-041992436e7f7214317f2af2ba8523df9896f54b7294d58a
ToppCellBronchial-10x5prime-Immune_Myeloid-Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TESPA1 TANC1 SYTL2

1.61e-041992435f499595597c10857bba8272f62afe4d32d733ac
ToppCellBronchial-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SPECC1 TESPA1 SYTL2

1.63e-0420024396540be0e906bbc626049a41978be3dc051d2024
ToppCellParenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SPECC1 TESPA1 SYTL2

1.63e-042002439156f8fd61a833891d2f7b7fadd693b81b1e2d5a
ToppCellCOVID-19-COVID-19_Mild-Myeloid-cDC|COVID-19_Mild / Disease, condition lineage and cell class

SPECC1 CD300C DST

1.63e-04200243b8f52e65813d331c49cdd5f354fdfec6fc8c339e
ToppCellParenchymal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SPECC1 TESPA1 SYTL2

1.63e-042002438943278190f42016ee914e584d1b6b9aeaf7c73f
ToppCellBronchial-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SPECC1 TESPA1 SYTL2

1.63e-0420024341d7736427494cb30a2f23722ea2b86ff308cfd8
ToppCellNS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MUC16 MAP3K13 SYTL2

1.63e-0420024364462a18afca3c1a8548a857924b8166058bf958
ToppCellsevere-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SPECC1 CD300C DST

1.63e-0420024323e3d2fb86a71f62cca32640842fbba5dd163453
ToppCellParenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SPECC1 TESPA1 SYTL2

1.63e-04200243566fe2e78e6f35399ec6aad5964f6d4d8ade82c6
ToppCellMS-IIF-Myeloid-cDC|IIF / Disease, condition lineage and cell class

SPECC1 CD300C DST

1.63e-04200243620a82805619d113182d59740670c9f9b93ee924
ToppCellBiopsy_Control_(H.)-Immune-Mast_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

SPECC1 TESPA1 SYTL2

1.63e-0420024364bf125e0e5652a5a638a6bb32eb109cb0d5e232
ToppCellsevere-cDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SPECC1 CD300C DST

1.63e-0420024326e04ea276dbca5cde48335c401269c7123b54d2
ToppCellParenchymal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SPECC1 TESPA1 SYTL2

1.63e-04200243ea52df18400550b65de142d03b3b0963436e03d9
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LZTS3 WWC1

1.26e-0398242ffe21b3681fdeaf4a8447bd2b13772d03cdd45aa
ToppCellParenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 MUC5B

1.52e-0310824275d635fc5bb004418db2e1328c24d96b718f10b1
ToppCellParenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 MUC5B

1.52e-031082429c7f3e25facfb54ef0be45044999bc36438bbea0
ToppCell3'_v3-bone_marrow-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|bone_marrow / Manually curated celltypes from each tissue

TESPA1 WWC1

2.16e-03129242426dfed68ce7ccc38d02e671e722e201f9eb1ce0
DrugCorticosterone [50-22-6]; Up 200; 11.6uM; HL60; HT_HG-U133A

LZTS3 APC CAMSAP2 CAPRIN1

2.99e-051892241307_UP
Druggenistein; Down 200; 10uM; MCF7; HT_HG-U133A

HSF2 APC CAPRIN1 SYTL2

3.25e-051932245232_DN
DrugChenodiol [474-25-9]; Up 200; 10.2uM; PC3; HT_HG-U133A

HSF2 APC TESPA1 SYTL2

3.45e-051962247310_UP
DrugAllantoin [97-59-6]; Up 200; 25.2uM; HL60; HT_HG-U133A

LZTS3 APC CAMSAP2 CD300C

3.52e-051972241842_UP
DrugSC-560; Down 200; 10uM; PC3; HT_HG-U133A

APC TESPA1 MUC5B CD300C

3.59e-051982246865_DN
DrugNiacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A

LZTS3 APC MUC5B MED1

3.66e-051992243381_DN
Diseasecholangiocarcinoma (is_marker_for)

MUC16 MUC3A MUC5B

1.46e-0564223DOID:4947 (is_marker_for)
DiseaseGastrointestinal Hemorrhage

APC SLC5A6

1.90e-059222C0017181
Diseasenucleus accumbens volume change measurement

MUC16 WWC1

2.91e-0511222EFO_0021493
Diseasecolorectal cancer, colorectal adenoma

MUC22 APC TANC1

1.92e-04152223EFO_0005406, MONDO_0005575
Diseasepancreatic ductal carcinoma (is_marker_for)

MUC3A MUC5B

9.46e-0461222DOID:3587 (is_marker_for)
DiseaseNonorganic psychosis

MED12 WWC1

1.21e-0369222C0349204
Diseasenicotine dependence

CAMSAP2 TANC1

1.54e-0378222EFO_0003768
Diseasedepressive symptom measurement, response to antidepressant

MUC5B MAP3K13

1.95e-0388222EFO_0007006, GO_0036276
DiseasePsychotic Disorders

MED12 WWC1

2.56e-03101222C0033975

Protein segments in the cluster

PeptideGeneStartEntry
PAASSGMKSSKSSTS

SPECC1

26

Q5M775
MPSATSHSGSGSKSS

CAPRIN1

1

Q14444
GSSSGSSGFKSVMSS

DNAJB8

171

Q8NHS0
TTTASSPQSSMGTSG

CD300C

136

Q08708
TGSMATPSSSTQTSG

MUC5B

2671

Q9HC84
TGSMATPSSSTQTSG

MUC5B

3371

Q9HC84
TGSMATPSSSTQTSG

MUC5B

4661

Q9HC84
SSGSEGTSSGTKMST

MUC16

7836

Q8WXI7
ASSKSGSSSSMGRPG

LZTS3

281

O60299
SGSSSGTMATLTISG

IGLV3-10

81

A0A075B6K4
LSSSMQSLSSGSSPG

WWC1

426

Q8IX03
SGLGTSTMGASSTTS

MUC22

1596

E2RYF6
TSSSMTSGLSSGMTS

DST

531

Q03001
KGTSAMTSSPSTTTA

MUC3A

181

Q02505
SLTPSKGKTSGTTSS

COIL

301

P38432
TGSSSGSTASNMPSS

MED12

1396

Q93074
ASPLSGSPKMSTSSS

MAP3K13

566

O43283
TSTSSSASGGLGMTV

FAM102A

261

Q5T9C2
GSSASSSSGVKMTSF

CAMSAP2

686

Q08AD1
GTSSSSGMKSSSGLG

MED1

1236

Q15648
SLSSGSDGSSPLMSS

HSF2

311

Q03933
KSPSSLTNLSSSSGM

SYTL2

591

Q9HCH5
LSPTSGTSVGMSTFS

SLC5A6

11

Q9Y289
TSSGSSGSPSSSIKM

TANC1

1661

Q9C0D5
SGSPSSSIKMSSSTS

TANC1

1666

Q9C0D5
PSTASTKSSGSGKMS

APC

2351

P25054
TKSSGSGKMSYTSPG

APC

2356

P25054
SSSMTGGTNKTSSSI

TESPA1

136

A2RU30
SGSMGSTTSVSSGTA

TRIP12

951

Q14669